New York, New York –June 4, 2012 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for
Cleveland BioLabs, Inc. (Nasdaq:CBLI), making gains of $0.68 or (53.54%) to trade at $1.95 12:36PM EDT on over 2.5 Million shares. The stock has a day’s high of $2.40.
The Company reported today
strong survival results for its randomized, blinded, placebo-controlled
efficacy study of CBLB502 in 179 non-human primates (NHPs) conducted
under Good Laboratory Practice (GLP) with elements of Good Clinical
Practice (GCP), as required by the U.S. Food and Drug Administration's
(FDA) Animal Rule. The study demonstrated with a high degree of
statistical significance the dose-response relationship between the
administration of CBLB502 and the survival of lethally irradiated
animals, the study's primary endpoint.
About Cleveland BioLabs, Inc.
Cleveland
BioLabs, Inc. is a clinical-stage biotechnology company leveraging deep
mechanistic understanding of the cell death process, apoptosis, to
develop a robust pipeline of compounds primarily focused on oncology
applications and mitigation of radiation injury. The Company's lead
compound is being developed as both a radiation countermeasure and a
direct acting anticancer agent. The Company has two operating
subsidiaries, Incuron, LLC, and Panacela Labs, Inc., and strategic
relationships with the Cleveland Clinic, Roswell Park Cancer Institute,
the Children's Cancer Institute of Australia
and the Armed Forces Radiobiology Research Institute. To learn more
about Cleveland BioLabs, Inc., please visit the Company's website at http://www.cbiolabs.com.
About InvestorIdeas.com:
InvestorIdeas.com
is a leader in investor stock research by sector. Sectors we cover
include; water and renewable energy stocks, biotech stocks, mining and
gold stocks, energy stocks, natural gas stocks, tech (includes cloud and
social networking), defense stocks, nanotech, China stocks and agriculture.
Sign up for the free investor news and stock alerts http://www.investorideas.com/
Research biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/
Become an Investorideas.com Member
Disclaimer/ Disclosure :
The Investorideas.com is a third party publisher of news and research
Our sites do not make recommendations, but offer information portals to
research news, articles, stock lists and recent research. Nothing on our
sites should be construed as an offer or solicitation to buy or sell
products or securities. This site is currently compensated by featured
companies, news submissions and online advertising.
BC
Residents and Investor Disclaimer : Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents
with Sedar. Read for more info: http://www.bcsc.bc.ca/release.
No comments:
Post a Comment